Stock GLYC GLYCOMIMETICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart GlycoMimetics, Inc.

Equities

GLYC

US38000Q1022

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-15 pm EDT 		5-day change 1st Jan Change
0.27 USD -2.17% Intraday chart for GlycoMimetics, Inc. -9.52% -88.56%
May. 09 GlycoMimetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 07 Capital One Downgrades GlycoMimetics to Equalweight, Price Target at $0.50 MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
GLYCOMIMETICS, INC. Stock GlycoMimetics, Inc.
 17.4M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 113B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 22.22B -
ARGENX SE Stock argenx SE
 22.27B -
GENMAB A/S Stock Genmab A/S
 19.43B
  1. Stock Market
  2. Equities
  3. GLYC Stock
  4. Charts GlycoMimetics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW